Market Size of France Nuclear Imaging Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Market Size (2024) | USD 412.91 Million |
| Market Size (2029) | USD 483.58 Million |
| CAGR (2024 - 2029) | 3.21 % |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
France Nuclear Imaging Market Analysis
The France Nuclear Imaging Market size is estimated at USD 412.91 million in 2024, and is expected to reach USD 483.58 million by 2029, growing at a CAGR of 3.21% during the forecast period (2024-2029).
During the COVID-19 pandemic, the nuclear imaging market in France was significantly affected as a result of lockdown and restrictions on non-essential procedures. According to a study titled 'Quantitative impact of the first COVID-19 lockdown on nuclear medicine in France: the CORALINE study' published in the National Center for Biotechnology Information in June 2021, the total number of nuclear medicine examinations performed in France dropped by 43.4% in the time span of 4 weeks before and after the lockdown. However, after the COVID-19 pandemic, the market is gaining its momentum back. Therefore, it is observed that despite the decrease in utilization of nuclear imaging during the pandemic, the market is believed to witness steady growth in the coming years.
The studied market growth can largely be attributed to factors, such as the increasing prevalence of cancer and cardiac disorders, and technological advancements in nuclear imaging. Morover, according to the United Nations Population Fund's World Population Dashboard's Statistics 2021, in France, there are about 21.1% of people aged 65 years and above. As the older population is most likely to get affected by chronic diseases, the need for devices for monitoring, diagnosis, and treatment is expected to increase over the forecast period. Thereby boosting the growth of the market studied.
Additionally, technological advancements in nuclear imaging are augmenting the growth of the market studied in France. For instance, in May 2022, physicians from Baclesse Cancer Center, France demonstrated that an artificial intelligence (AI) program can enhance image quality in half-count F-18 FDG-PET scans, opening the door to large acquisition time reductions in standard clinical practice. With the findings from various studies, nuclear medicine specialists from France have started implementing advanced technologies in PET/SPECT scans which is expected to contribute to the growth of the market studied.
